Compare ARK Genomic Revolution ETF (ARKG) vs VanEck Australian Floating Rate ETF (FLOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs VanEck Australian Floating Rate ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.28, while VanEck Australian Floating Rate ETF trades at $51. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, VanEck Australian Floating Rate ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | FLOT | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $51.09 |
52-Week Low | $23.09 | $50.72 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FLOT trades at $50.98 with minimal daily movement (+0.02%). Technical indicators show a bullish trend with moving averages supporting upward momentum, though oscillators remain neutral. The ETF maintains consistent dividend distributions, with recent payments of $0.17-$0.18 per share. Market sentiment focuses on floating rate bond exposure amid potential Federal Reserve rate hikes.
FLOT offers exposure to high-quality floating rate bonds with a 4.0% SEC yield, positioning it favorably in a rising rate environment. Key risks include interest rate volatility and credit quality concerns. Analyst consensus leans neutral, with the ETF serving as a cash alternative with modest yield premium over Treasury bills.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About VanEck Australian Floating Rate ETF
FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →
